Portland,OR, July 24, 2023 (GLOBE NEWSWIRE) -- Allied Market Research has recently published a report, titled, “Clot Busting Drugs Market by Product (Thrombolytic Drugs, Anti-Platelet Drugs, Anticoagulants, Others), by Indication (Pulmonary Embolism, Deep Vein Thrombosis, Atrial Fibrillation, Others), by Route of Administration (Oral, Injectable), by Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy): Global Opportunity Analysis and Industry Forecast, 2023-2032”. According to the report, the global clot busting drugs market generated $28.6 billion in 2022, and is anticipated to generate $60 billion by 2032, witnessing a CAGR of 8.2% from 2023 to 2032.
Request Sample of the Report - https://www.alliedmarketresearch.com/request-sample/32353
Prime Determinants of Growth
Over the years, there has been an increase in the prevalence of cardiovascular diseases across the world which has led to an increase in demand for clot busting drugs. This growth in demand is predicted to be one of the important factors driving the growth of the global clot busting drugs market in the forecast timeframe. However, increase in bleeding risk associated with clot busting drugs may hamper the clot busting drugs market growth in the coming period. On the contrary, technological advancements in diagnostic imaging such as computed tomography (CT) scans and magnetic resonance imaging (MRI) is expected to offer growth opportunities for expansion of the clot busting drugs market in the 2023-2032 forecast period.
Report Coverage & Details:
| Report Coverage | Details |
| Forecast Period | 2023–2032 |
| Base Year | 2022 |
| Market Size in 2022 | $28.6 billion |
| Market Size in 2032 | $60 billion |
| CAGR | 8.2% |
| No. of Pages in Report | 280 |
| Segments covered | Product, Indication, Route of Administration, Distribution Channel, and Region |
| Drivers | Increasing prevalence of cardiovascular diseases across the world The numerous advantages offered by clot busting drugs in treatment of certain ailments such as ischemic strokes or myocardial infarctions |
| Opportunities | Technological advancements in diagnostic imaging including computed tomography (CT) scans and magnetic resonance imaging (MRI) The rising incidence of strokes leading to increasing demand for personalized medicine approaches |
| Restraints | Increase in bleeding risk associated with clot busting drugs |
COVID-19 Scenario
- The outbreak of the COVID-19 pandemic has had a substantial influence on the growth of the global clot busting drugs market. The pandemic saw a shift in focus towards treating COVID-19 patients which resulted in delays in the diagnosis and treatment of non-COVID conditions, including thrombotic disorders. This resulted in a decrease in demand for clot busting drugs which affected the growth rate of the market.
- Also, there were severe disruptions in healthcare services including elective procedures, non-emergency hospital visits, and outpatient care which further declined the growth rate of the market.
- The clot busting drugs market is, however, projected to show steady growth in the future due to innovations in diagnostic imaging technology.
Procure Complete Report (280 Pages PDF with Insights, Charts, Tables, and Figures)
https://www.alliedmarketresearch.com/checkout-final/clot-busting-drugs-market
Product: Anticoagulants Sub-segment Projected to be Highly Dominant During the Forecast Period
The anticoagulants sub-segment accounted for the highest clot busting drugs market share in 2022 and is expected to continue to maintain its dominance during the forecast period. In the last few years, there has been an overall increase in occurrences of coagulation disorders which has led to a growth in demand for anticoagulants. This growth in demand for such drugs is predicted to boost the sub-segment’s growth by 2032.
Indication: Pulmonary Embolism Sub-segment to be Flourish Immensely by 2032
The pulmonary embolism sub-segment generated the highest market share in 2022 and is predicted to hold the majority of market share by 2032 as well. The growing usage and need for clot busting drugs due to rise in number of people receiving chemotherapy or having a family history of pulmonary embolism is predicted to boost the sub-segment’s growth by 2032.
Route of Administration: Injectable Sub-segment Projected to Garner a Huge Market Share by 2032
The injectable sub-segment accounted for the highest clot busting drugs market share in 2022 and is expected to grow at a fascinating CAGR of 8.7% during the forecast period. Injectable versions of clot-busting medicines have a higher bioavailability than oral or topical delivery. As a result, injectable drugs are in a heavy demand which is predicted to boost the sub-segment’s growth by 2032.
Distribution Channel: Hospital Pharmacy Sub-segment to Grow Rapidly by 2032
The hospital pharmacy sub-segment generated the highest market share in 2022 and is predicted to grow at a high CAGR of 8.9% by 2032. Increasing role of hospital pharmacies in procuring and storing of clot busting drugs to ensure prompt administration during critical situations is predicted to boost the sub-segment’s growth by 2032.
For Purchase Inquiry - https://www.alliedmarketresearch.com/purchase-enquiry/32353
North America Market to be One of the Fastest Growing by 2032
The North America region accounted for the highest share in the global clot busting drugs market in 2022 and is expected to witness fastest growth during the forecast period. The increasing proportion of aging population in this region and the growing prevalence of cardiovascular illnesses are expected to be the main growth drivers of the market in North America region by 2032.
Leading Players in the Clot Busting Drugs Market:
The report provides a detailed analysis of the key players of the global clot busting drugs market. These players have adopted different strategies, such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain their dominance in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Browse More Trending Reports in Healthcare Industry By AMR -
Pharmaceutical Suppositories Market - Global Opportunity Analysis and Industry Forecast, 2020-2030
Orthopedic Implants Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
3D Printed Drugs Market- Global Opportunity Analysis and Industry Forecast, 2020–2030
Wearable Injectors Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
Computed Tomography (CT) Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
Empty Capsules Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter
